JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263336

Human RTN4RL2 (NgR2) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

RTN4RL2 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon2.

View Alternative Names

NGRH1, NGRL3, NgR2, Nogo receptor-like 3, Nogo-66 receptor homolog 1, Nogo-66 receptor-related protein 2, R4RL2_HUMAN, RTN4RL2, Reticulon-4 receptor-like 2

1 Images
Sanger Sequencing - Human RTN4RL2 (NgR2) knockout HeLa cell lysate (AB263336)
  • Sanger seq

Unknown

Sanger Sequencing - Human RTN4RL2 (NgR2) knockout HeLa cell lysate (AB263336)

Homozygous : 10 bp deletion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263336-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human RTN4RL2 knockout HeLa cell lysate", "number":"AB263336-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263336-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
RTN4RL2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NgR2 also known as Nogo receptor 2 or Reticulon 4 receptor 2 is a glycosylphosphatidylinositol (GPI)-anchored protein with a molecular mass of approximately 55 kDa. It is mainly expressed in the central nervous system where it functions as an axon guidance receptor. NgR2 binds to myelin-associated proteins including myelin-associated glycoprotein (MAG) oligodendrocyte myelin glycoprotein (OMgp) and Nogo-A inhibiting axon regeneration in the adult nervous system. This protein is important for maintaining neuronal architecture and regulating neuronal growth.
Biological function summary

The action of NgR2 impacts the neural regeneration processes by forming a receptor complex with p75 neurotrophin receptor (p75NTR) and LINGO-1. This complex activation inhibits axonal outgrowth and neural plasticity which affects the nervous system's ability to recover after injury. NgR2 mediates signaling that prevents neurite outgrowth contributing to the stabilization of neuronal connections in postnatal brain development. NgR2's role in these processes makes it a significant target for studies investigating neuronal repair mechanisms.

Pathways

Axon guidance and myelin inhibition play significant roles in the function of NgR2. It participates in the RhoA-ROCK signaling pathway which is activated upon myelin ligand binding to the receptor complex. This pathway is responsible for cytoskeletal changes that inhibit neurite extension. Additionally NgR2 interacts with proteins such as Nogo-A and MAG further influencing axonal growth inhibition and regeneration in the nervous system.

Defects in NgR2 function or expression can relate to conditions such as spinal cord injury and multiple sclerosis. These disorders exhibit impaired neural repair and regeneration where NgR2 and its associated proteins like Nogo-A and MAG play a role in limiting recovery and repair mechanisms. Understanding the interactions and regulation of NgR2 in these contexts can provide insights into therapeutic approaches aimed at enhancing neural regeneration and functional recovery.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com